CMMB Stock Analysis: Buy, Sell, or Hold?
CMMB - Chemomab Therapeutics Ltd. American Depositary Share
$1.56
0.04 (2.63%)
▲
5d:
-10.34%
30d:
-4.88%
90d:
-6.59%
HOLD
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 13, 2026
25d
Get Alerted When CMMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CMMB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CMMB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CMMB is currently trading at $1.56, which is considered slightly low relative to its 30-day fair value range of $1.43 to $2.02.
Technical Outlook: Technically, CMMB is showing sideways momentum. Immediate support is located at $1.49, while resistance sits at $2.83.
Market Sentiment: CMMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+220.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CMMB is showing sideways momentum. Immediate support is located at $1.49, while resistance sits at $2.83.
Market Sentiment: CMMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+220.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.43 -
$2.02
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 220.5% below Wall St target ($5.00)
- CAUTION: 5-day price weakness (-10.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.43 -
$2.02
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.49
Resistance Level
$2.83
Current Trend
Sideways
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-52.00
Wall Street Target
$5.00
(+220.5%)
Share & Embed Analysis
Last updated: July 18, 2026 3:46 AM ET
Data refreshes hourly during market hours. Next update: 4:46 AM
Data refreshes hourly during market hours. Next update: 4:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 53 HOLD |
